Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go t0 《Privacy Policy Statement》

中
En
About Us
Overview
Founder
Platform
Milestones
Culture
Honors
Core Technology
Technological platforms
Pipeline
Academic achievements
Clinical Trials
News
Company News
Join Us
Social Recruitment
Campus Recruitment
Contact
linchuangshiyan.jpg d1_banph.jpg

Clinical Trials
A Phase I clinical trial of the autologous genetically modified TIL (GC203) for the treatment of advanced malignant solid tumors（KunLun-001）

Fudan University Shanghai Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Tenth People’s hospital of Tongji University, The Second Affiliated Hospital Zhejiang University School of Medicine, etc.

Learen More +
A Phase I clinical trial of the autologous natural TIL (GC101) for the treatment of advanced malignant solid tumors

Chinese PLA General Hospital

Learen More +
A Phase I clinical trial of the autologous natural TIL (GC101) for the treatment of advanced malignant solid tumors

Fudan University Shanghai Cancer Center

Learen More +
A Phase I clinical trial of the autologous natural TIL (GC101) for the treatment of advanced malignant solid tumors

Tenth People's Hospital of Tongji University

Learen More +
A clinical study of TILs expressing membrane-bound cytokines for the treatment of advanced gynecologic tumors

Tenth People's Hospital of Tongji University

Learen More +